{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:43:13Z","timestamp":1787269393304,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC1719304"],"award-info":[{"award-number":["2019YFC1719304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017555","name":"Zhejiang University Student Science and Technology Innovation Activity Plan","doi-asserted-by":"publisher","award":["S202310412094"],"award-info":[{"award-number":["S202310412094"]}],"id":[{"id":"10.13039\/501100017555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The successful launch of icaritin, a therapeutic drug for liver cancer derived from <jats:italic>Epimedium\u00a0brevicornu<\/jats:italic>, has provided new impetus for the development of prenylated flavonoids in the field of oncology.<jats:italic> Flemingia macrophyll<\/jats:italic>a is reported to contain characteristic prenylated flavonoids which can regulate the p53 protein. We aimed to isolate these constituents and conduct activity evaluation, structure\u2013activity relationship, and mechanism studies to provide candidate compounds for antitumor drug development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, chromatographic techniques combined with spectroscopic methods were used to separate, purify, and identify the constituents of <jats:italic>Flemingia macrophylla<\/jats:italic> methanol extract. The cytotoxic activity of the constituents was evaluated using an MTT assay with A549 and H1975 cells as the model. The binding mechanism between the compounds and the p53 protein was investigated with molecular docking and validated with cellular thermal shift assay (CETSA). Western blotting (WB) was employed to detect the expression of p53 protein and apoptosis-related proteins in cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Chiral HPLC separation of racemates <jats:bold>1<\/jats:bold> and <jats:bold>7<\/jats:bold> provided two pairs of undescribed enantiomers (<jats:bold>1a<\/jats:bold>\/<jats:bold>1b<\/jats:bold> and <jats:bold>7a<\/jats:bold>\/<jats:bold>7b<\/jats:bold>), along with eight known compounds (<jats:bold>2<\/jats:bold>\u2009\u2212\u2009<jats:bold>9<\/jats:bold>) isolated from <jats:italic>Flemingia macrophylla<\/jats:italic> roots. Their structures were elucidated by spectroscopic analysis, and the absolute configurations of the enantiomers were determined from experimental and calculated electronic circular dichroism data. Compounds <jats:bold>1<\/jats:bold>\u2009\u2212\u2009<jats:bold>7<\/jats:bold>, and the non-prenyl analogues <jats:bold>10<\/jats:bold>\u2009\u2212\u2009<jats:bold>13<\/jats:bold>, were evaluated for cytotoxic activity against the human lung cancer A549 and H1975 cell line. Compounds 5\u2009\u2212\u20097 displayed better cytotoxicity than the positive control icaritin in A549 and H1975, with IC<jats:sub>50<\/jats:sub> values ranging from 4.50 to 19.83\u00a0\u03bcmol\u00b7L<jats:sup>-1<\/jats:sup> and\u2009&lt;\u20095\u00a0\u03bcmol\u00b7L<jats:sup>-1<\/jats:sup>, respectively. The structure\u2013activity relationships of the chromone or flavonoid analogues against A549 cells were discussed. Molecular docking results demonstrated that compound <jats:bold>7a<\/jats:bold> has strong interaction with p53 and WB indicated that <jats:bold>7a<\/jats:bold> induced apoptosis by increasing the p53 protein, decreasing the anti-apoptotic protein Bcl-2, and activating the caspase family in A549 cells. These results suggest that prenylated flavonoids are potential p53 protein activators.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrates that <jats:italic>Flemingia macrophylla<\/jats:italic> is rich in prenylated flavonoid constituents, among which compounds 5 and 7 exhibited significant cytotoxic activity against A549 cells and served as reference candidates for the design and development of prenylated compounds as antitumor therapeutic drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13020-023-00860-3","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:02:03Z","timestamp":1700755323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prenylated chromones and flavonoids isolated from the roots of Flemingia macrophylla and their anti-lung cancer activity"],"prefix":"10.1186","volume":"18","author":[{"given":"Baolin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyikun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-750X","authenticated-orcid":false,"given":"Hongwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"3","key":"860_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Ca-Cancer J Clin"},{"issue":"8","key":"860_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/cancers10080248","volume":"10","author":"U Testa","year":"2018","unstructured":"Testa U, Castelli G, Pelosi E, et al. Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells. Cancers. 2018;10(8):248\u2013248.","journal-title":"Cancers"},{"key":"860_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00571-8","author":"O Hassin","year":"2022","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2022. https:\/\/doi.org\/10.1038\/s41573-022-00571-8.","journal-title":"Nat Rev Drug Discov"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","volume":"85","author":"AC Joerger","year":"2016","unstructured":"Joerger AC, Fersht AR, Kornberg RD, et al. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem. 2016;85:375\u2013404.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"860_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11596-014-1305-1","volume":"34","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Liu W, Li B, et al. Anticancer efect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis. J Huazhong Univ Sci Technol (Med Sci). 2014;34(4):497\u2013503.","journal-title":"J Huazhong Univ Sci Technol (Med Sci)"},{"issue":"11","key":"860_CR6","first-page":"4628","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Meng X, Jin L, et al. Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells. Am J Transl Res. 2016;8(11):4628\u201343.","journal-title":"Am J Transl Res"},{"issue":"4","key":"860_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2018.08.060","volume":"504","author":"S Han","year":"2018","unstructured":"Han S, Gou Y, Jin D, et al. Effects of icaritin on the physiological activities of esophageal cancer stem cells. Biochem Bioph Res Co. 2018;504(4):792\u20136.","journal-title":"Biochem Bioph Res Co"},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.lfs.2018.03.059","volume":"202","author":"L Gao","year":"2018","unstructured":"Gao L, Chen M, Ouyang Y, et al. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt\/mTOR pathway. Life Sci. 2018;202:188\u201394.","journal-title":"Life Sci"},{"key":"860_CR9","unstructured":"The Chinese Editorial Committee of the Flora of China, Chinese Academy of Sciences. Flora of China (Volume 41). Beijing: Science Press, 1995."},{"issue":"2","key":"860_CR10","first-page":"274","volume":"5990","author":"MSH Kabir","year":"2016","unstructured":"Kabir MSH, Habib IB, Hossain MK, et al. In silico pass prediction and molecular docking of isolated compounds from Flemingia macrophylla for thormbolytic effect. World J Pharm Res. 2016;5990(2):274\u201383.","journal-title":"World J Pharm Res"},{"key":"860_CR11","first-page":"476","volume-title":"The Editorial Board of Chinese Materia Medic","author":"State Administration of Traditional Chinese Medicine of China","year":"1999","unstructured":"State Administration of Traditional Chinese Medicine of China. The Editorial Board of Chinese Materia Medic. Shanghai: Shanghai Science and Technology Press; 1999. p. 476."},{"key":"860_CR12","first-page":"696879","volume":"4","author":"HM Chiang","year":"2013","unstructured":"Chiang HM, Chiu HH, Liao ST, et al. Isoflavonoid-rich Flemingia macrophylla extract attenuates UVB-Induced skin damage by scavenging reactive oxygen species and inhibiting MAP kinase and MMP expression. Evid-Based Compl Alt. 2013;4:696879.","journal-title":"Evid-Based Compl Alt"},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1055\/s-2005-871297","volume":"71","author":"YJ Shiao","year":"2005","unstructured":"Shiao YJ, Wang CN, Wang WY, et al. Neuroprotective flavonoids from Flemingia macrophylla. Planta Med. 2005;71:835\u201340.","journal-title":"Planta Med"},{"key":"860_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nep179","author":"HY Ho","year":"2011","unstructured":"Ho HY, Wu JB, Lin WC, et al. Flemingia macrophylla extract ameliorates experimental osteoporosis in ovariectomized rats. Evid-Based Compl Alt. 2011. https:\/\/doi.org\/10.1093\/ecam\/nep179.","journal-title":"Evid-Based Compl Alt"},{"issue":"1","key":"860_CR15","first-page":"795843","volume":"2012","author":"LL Yun","year":"2012","unstructured":"Yun LL, Huey JT, Yung FL, et al. The components of Flemingia macrophylla attenuate amyloid \u03b2-Protein accumulation by regulating amyloid \u03b2-Protein metabolic pathway. Evid-Based Compl Alt. 2012;2012(1):795843.","journal-title":"Evid-Based Compl Alt"},{"issue":"3","key":"860_CR16","first-page":"349","volume":"39","author":"JS Deng","year":"2012","unstructured":"Deng JS, Chang YC, Wen CL, et al. Hepatoprotective effect of the aqueous extract of Flemingia macrophylla on carbon tetrachloride-induced acute hepatotoxicity in rats through anti-oxidative activities. J Ethnopharmacol. 2012;39(3):349\u201365.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"860_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1142\/S0192415X1000810X","volume":"38","author":"JK Yu","year":"2010","unstructured":"Yu JK, Tsung CL, Susumu K, et al. Analgesic and anti-inflammatory activities of the aqueous extracts from three Flemingia species. Am J Chinese Med. 2010;38(3):625\u201338.","journal-title":"Am J Chinese Med"},{"issue":"21","key":"860_CR18","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1016\/j.bmc.2013.08.049","volume":"21","author":"Y Wang","year":"2013","unstructured":"Wang Y, Curtis LMJ, Yuk HJ, et al. Bacterial neuraminidase inhibitory effects of prenylated isoflavones from roots of Flemingia philippinensis. Bio org Med Chem. 2013;21(21):6398\u2013404.","journal-title":"Bio org Med Chem"},{"issue":"5","key":"860_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1248\/bpb.31.908","volume":"31","author":"HA Jung","year":"2008","unstructured":"Jung HA, Jeong DM, Chung HY, et al. Re-evaluation of the antioxidant prenylated flavonoids from the roots of Sophora flavescens. Biol Pharm Bull. 2008;31(5):908\u201315.","journal-title":"Biol Pharm Bull"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"105748","DOI":"10.1016\/j.phrs.2021.105748","volume":"170","author":"RYK Yuan","year":"2021","unstructured":"Yuan RYK, Zhao WT, Wang QQ, et al. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis. Pharmacol Res. 2021;170:105748.","journal-title":"Pharmacol Res"},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"104576","DOI":"10.1016\/j.jff.2021.104576","volume":"84","author":"L Luo","year":"2021","unstructured":"Luo L, Wang Y, Wang YH, et al. Potential in vitro anti-neuroinflammatory sterols from mango fruits (Mangifera indica L.). J Funct Foods. 2021;84:104576.","journal-title":"J Funct Foods"},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"846384","DOI":"10.3389\/fimmu.2022.846384","volume":"13","author":"S Han","year":"2022","unstructured":"Han S, Yuan RYK, Cui YS, et al. Hederasaponin C alleviates lipopolysaccharide-induced acute lung injury. Front Immunol. 2022;13:846384.","journal-title":"Front Immunol"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"154884","DOI":"10.1016\/j.phymed.2023.154884","volume":"116","author":"QM Fang","year":"2023","unstructured":"Fang QM, Liang XW, Xu ZP, et al. Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways. Phytomedicine. 2023;116:154884.","journal-title":"Phytomedicine"},{"issue":"7","key":"860_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/np800079c","volume":"71","author":"AB Alarc\u00f3n","year":"2008","unstructured":"Alarc\u00f3n AB, Cuesta-Rubio O, P\u00e9rez JC, et al. Constituents of the cuban endemic species Calophyllum Pinetorum. J Nat Prod. 2008;71(7):1283\u20136.","journal-title":"J Nat Prod"},{"issue":"6","key":"860_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0031-9422(96)00494-3","volume":"43","author":"WG Ma","year":"1996","unstructured":"Ma WG, Fuzzati N, Lu SL, et al. Further chromones from Eriosema tuberosum. Phytochemistry. 1996;43(6):1339\u201343.","journal-title":"Phytochemistry"},{"issue":"6","key":"860_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/chir.22600","volume":"28","author":"G Pescitelli","year":"2016","unstructured":"Pescitelli G, Bruhn T. Good computational practice in the assignment of absolute configurations by TDDFT calculations of ECD spectra. Chirality. 2016;28(6):466\u201374.","journal-title":"Chirality"},{"issue":"12","key":"860_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mrc.2336","volume":"46","author":"H Li","year":"2008","unstructured":"Li H, Yang M, Miao J, et al. Prenylated isoflavones from Flemingia philippinensis. Magn Reson Chem. 2008;46(12):1203\u20137.","journal-title":"Magn Reson Chem"},{"issue":"3","key":"860_CR28","first-page":"509","volume":"34","author":"W Rui","year":"2012","unstructured":"Rui W, Fan X, Cen YZ, et al. Analysis of flavonoids in Flemingia philippinensis Merr. et Rolfe. by UPLC\/Q-TOF-MS. Chin Tradit Pat Med. 2012;34(3):509\u201313.","journal-title":"Chin Tradit Pat Med"},{"issue":"8","key":"860_CR29","doi-asserted-by":"publisher","first-page":"15578","DOI":"10.3390\/ijms140815578","volume":"14","author":"W Lai","year":"2013","unstructured":"Lai W, Tsui Y, Singab A, et al. Phyto-SERM constitutes from Flemingia macrophylla. Ijms. 2013;14(8):15578\u201394.","journal-title":"Ijms"},{"issue":"6","key":"860_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/np900021h","volume":"72","author":"S Sutthivaiyakit","year":"2009","unstructured":"Sutthivaiyakit S, Thongnak O, Lhinhatrakool T, et al. Cytotoxic and antimycobacterial prenylated flavonoids from the roots of Eriosema chinense. J Nat Prod. 2009;72(6):48\u20139.","journal-title":"J Nat Prod"},{"issue":"5","key":"860_CR31","first-page":"12","volume":"25","author":"HD Mai","year":"2019","unstructured":"Mai HD, Toan TP, Huu GT, et al. New flavonoid and stilbene derivatives from the fruits of Macaranga balansae. J Nat Prod. 2019;25(5):12\u20139.","journal-title":"J Nat Prod"},{"key":"860_CR32","first-page":"7","volume":"57","author":"M Patr\u00edcia","year":"2015","unstructured":"Patr\u00edcia M, Ana L, S\u00f3nia SF, et al. A new prenylisoflavone from Ulex jussiaei. Z Naturforsch C. 2015;57:7\u20138.","journal-title":"Z Naturforsch C"},{"issue":"2","key":"860_CR33","first-page":"8","volume":"31","author":"X Liu","year":"2012","unstructured":"Liu X, Feng X, Wang Q, et al. Chemical constituents and pharmacological research progress of plants in the genus Suaeda. Chin Wild Plant Resour. 2012;31(2):8\u201311.","journal-title":"Chin Wild Plant Resour"},{"issue":"10","key":"860_CR34","first-page":"1661","volume":"47","author":"J Shao","year":"2016","unstructured":"Shao J, Liu Y, Li X, et al. Chemical composition study of lotus plumule. Chin Tradit Herb Drugs. 2016;47(10):1661\u20134.","journal-title":"Chin Tradit Herb Drugs"},{"issue":"1","key":"860_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.etp.2005.05.008","volume":"57","author":"JV Castell","year":"2005","unstructured":"Castell JV, Donato MT, G\u00f3mez-Lech\u00f3n MJ. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. J Toxicol Pathol. 2005;57(1):189\u2013204.","journal-title":"J Toxicol Pathol"},{"key":"860_CR36","doi-asserted-by":"publisher","first-page":"112895","DOI":"10.1016\/j.phytochem.2021.112895","volume":"191","author":"SC Shi","year":"2021","unstructured":"Shi SC, Li JC, Zhao XM, et al. A comprehensive review: Biological activity, modification and synthetic methodologies of prenylated flavonoids. Phytochemistry. 2021;191:112895.","journal-title":"Phytochemistry"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2017.09.053","volume":"414","author":"NC Synnott","year":"2018","unstructured":"Synnott NC, Bauer MR, Madden S, et al. Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigation with the anti-p53 drug. Cancer Lett. 2018;414:99\u2013106.","journal-title":"Cancer Lett"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-023-00860-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:02:30Z","timestamp":1700755350000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-023-00860-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s13020-023-00860-3","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}